Our study found that there was no significant correlation between PPARG Pro12Ala and CKD in the Caucasian sample, whereas results in previous meta-analyses indicated that the PPARG Pro12Ala dominant model has a significant protective effect against CKD [32,33,34,37,38,39]. This evidence concerns the gene PPARG and chronic kidney disease.